Assessment of tumor size as a useful marker for the surgical staging of endometrial cancer
Assessment of tumor size as a useful marker for the surgical staging of endometrial cancer
复制标题
DOI：
10.3892/or.2014.3108
复制
发表时间：
2014-05-01
期刊：
影响因子：
4.2
通讯作者：
Gizzo, Salvatore
中科院分区：
文献类型：
--
作者：
Berretta, Roberto;Patrelli, Tito Silvio;Gizzo, Salvatore
越来越多的证据表明，估计肿瘤大小可能会改善子宫内膜癌的治疗。我们进行了一项观察性研究，旨在阐明肿瘤大小和其他普遍接受的预后因素之间的关系，以确定合适的术前参数，可以指导早期子宫内膜癌亚组的手术。我们发现，当肿瘤的大小增加，阶段和分级显着增加。肿瘤大小与血清CA 125值、淋巴结转移和腹腔细胞学状态相关。患有1级或2级子宫体癌、子宫肌层浸润的患者
Accumulating evidence suggests that the estimation of tumor size may improve endometrial cancer treatment. We conducted an observational study aimed at elucidating the association between tumor size and other universally accepted prognostic factors in order to identify suitable preoperative parameters which can guide surgery in a subgroup of early corpus endometrial cancer. We found that when tumor size increased, both stage and grading were significantly increased. Tumor size was correlated with CA 125 serum values, node metastasis and peritoneal cytology status. Patients who have grade 1 or 2 endometrioid corpus cancer, myometrial invasion